Probably Genetic
Patient Intelligence Platform for Genetic Disease
San Francisco, United States · Founded 2019 · $10.7M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2C
- Website
- probablygenetic.com
- Total Funding
- $10.7M
- Last Round
- $10.7M Series AMar 2024
- Rounds
- 2
About
Probably Genetic is changing the lives of patients living with severe, complex diseases. Our data platform is used by drug developers and patient advocacy groups to develop and launch treatments for these patients. Our technology discovers undiagnosed patients online, analyzes their disease state using machine learning and at-home testing, and enables compliant communication with patients. In doing so, we help patients access diagnoses, clinical trials, and treatments as early as possible.
Summary
Probably Genetic is a Biotech company based in San Francisco, United States, founded in 2019. It has raised $10.7M in total across 2 rounds, most recently a $10.7M Series A round in Mar 2024. Investors include Threshold Ventures, Khosla Ventures and Asymmetric Capital Partners.
Tech & App Stack
8 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company


